TNF May Negatively Regulate Phagocytosis of Devil Facial Tumour Disease Cells by Activated Macrophages

References

• Aderem A, Underhill DM. (1999). Mechanisms of phagocytosis in macrophages. Annu Rev Immunol, 17, 593–623. doi: 10.1146/annurev.immunol.17.1.593
   PubMed Web of Science ®Google Scholar
• Alvey C, Discher DE. (2017). Engineering macrophages to eat cancer: from “marker of self” CD47 and phagocytosis to differentiation. J Leukoc Biol, 102, 31–40. doi: 10.1189/jlb.4RI1216-516R
   PubMed Web of Science ®Google Scholar
• Borges VM, Vandivier RW, McPhillips KA, et al. (2009). TNFalpha inhibits apoptotic cell clearance in the lung, exacerbating acute inflammation. Am J Physiol Lung Cell Mol Physiol. 297, L586–595. doi: 10.1152/ajplung.90569.2008
   PubMed Web of Science ®Google Scholar
• Chan ED, Riches DW. (2001). IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/ SAPK,and p38(mapk) in a mouse macrophage cell line. Am J Physiol Cell Physiol, 280, C441–450. doi: 10.1152/ajpcell.2001.280.3.C441
   PubMed Web of Science ®Google Scholar
• Cohen HB, Ward A, Hamidzadeh K, et al. (2015). IFN-gamma prevents adenosine receptor (A2bR) upregulation to sustain the macrophage activation response. J Immunol, 195, 3828–3837. doi: 10.4049/jimmunol.1501139
   PubMed Web of Science ®Google Scholar
• Ding AH, Nathan CF, Stuehr DJ. (1988). Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol, 141, 2407–2412.
   PubMed Web of Science ®Google Scholar
• Feng X, Deng T, Zhang Y, et al. (2011). Lipopolysaccharide inhibits macrophage phagocytosis of apoptotic neutrophils by regulating the production of tumour necrosis factor alpha and growth arrest-specific gene 6. Immunology, 132, 287–295. doi: 10.1111/j.1365-2567.2010.03364.x
   PubMed Web of Science ®Google Scholar
• Fernandez-Boyanapalli R, McPhillips KA, Frasch SC, et al. (2010). Impaired phagocytosis of apoptotic cells by macrophages in chronic granulomatous disease is reversed by IFN-gamma in a nitric oxide-dependent manner. J Immunol, 185, 4030–4041. doi: 10.4049/jimmunol.1001778
   PubMed Web of Science ®Google Scholar
• Flies AS, Blackburn NB, Lyons AB, et al. (2017). Comparative analysis of immune checkpoint molecules and their potential role in the transmissible tasmanian devil facial Tumor Disease. Front Immunol, 8, 513. doi: 10.3389/fimmu.2017.00513
   PubMed Web of Science ®Google Scholar
• Gifford GE, Lohmann-Matthes ML. (1987). Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide. J Natl Cancer Inst, 78, 121–124.
   PubMedGoogle Scholar
• Gordon S, Martinez FO. (2010). Alternative activation of macrophages: mechanism and functions. Immunity, 32, 593–604. doi: 10.1016/j.immuni.2010.05.007
   PubMed Web of Science ®Google Scholar
• Hu S, Wei W, Korner H. (2017). The role of monocytes in models of infection by protozoan parasites. Mol Immunol, 88, 174–184. doi: 10.1016/j.molimm.2017.06.020
   PubMed Web of Science ®Google Scholar
• Jones ME, Cockburn A, Hamede R, et al. (2008). Life-history change in disease-ravaged Tasmanian devil populations. Proc Natl Acad Sci U S A, 105, 10023–10027. doi: 10.1073/pnas.0711236105
   PubMed Web of Science ®Google Scholar
• Jun CD, Han MK, Kim UH, Chung HT. (1996). Nitric oxide induces ADP-ribosylation of actin in murine macrophages: association with the inhibition of pseudopodia formation, phagocytic activity, and adherence on a laminin substratum. Cell Immunol, 174, 25–34. doi: 10.1006/cimm.1996.0290
   PubMed Web of Science ®Google Scholar
• Körner H, Cook M, Riminton DS, et al. (1997). Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol, 27, 2600–2609. doi: 10.1002/eji.1830271020
   PubMed Web of Science ®Google Scholar
• Kratochvill F, Neale G, Haverkamp JM, et al. (2015). TNF counterbalances the emergence of M2 tumor macrophages. Cell Rep, 12, 1902–1914. doi: 10.1016/j.celrep.2015.08.033
   PubMed Web of Science ®Google Scholar
• Kreiss A, Brown GK, Tovar C, et al. (2015). Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations. Vaccine, 33, 3016–3025. doi: 10.1016/j.vaccine.2015.01.039
   PubMed Web of Science ®Google Scholar
• Kreiss A, Obendorf DL, Hemsley S, et al. (2009). A histological and immunohistochemical analysis of lymphoid tissues of the Tasmanian devil. Anat Rec (Hoboken), 292, 611–620. doi: 10.1002/ar.20896
   PubMedGoogle Scholar
• Leichtle A, Hernandez M, Ebmeyer J, et al. (2010). CC chemokine ligand 3 overcomes the bacteriocidal and phagocytic defect of macrophages and hastens recovery from experimental otitis media in TNF-/- mice. J Immunol. 184, 3087–3097. doi: 10.4049/jimmunol.0901167
   PubMed Web of Science ®Google Scholar
• MacMicking J, Xie QW, Nathan C. (1997). Nitric oxide and macrophage function. Annu Rev Immunol, 15, 323–350. doi: 10.1146/annurev.immunol.15.1.323
   PubMed Web of Science ®Google Scholar
• Mannel DN, Moore RN, Mergenhagen SE. (1980). Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect. Immun., 30, 523–530.
   PubMed Web of Science ®Google Scholar
• McPhillips K, Janssen WJ, Ghosh M, et al. (2007). TNF-alpha inhibits macrophage clearance of apoptotic cells via cytosolic phospholipase A2 and oxidant-dependent mechanisms. J Immunol, 178, 8117–8126.
   PubMed Web of Science ®Google Scholar
• Murray PJ, Allen JE, Biswas SK, et al. (2014). Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 41, 14–20. doi: 10.1016/j.immuni.2014.06.008
   PubMed Web of Science ®Google Scholar
• Parameswaran N, Patial S. (2010). Tumor necrosis factor-alpha signaling in macrophages. Crit Rev Eukaryot Gene Expr, 20, 87–103.
   PubMed Web of Science ®Google Scholar
• Patel NR, Bole M, Chen C, et al. (2012). Cell elasticity determines macrophage function. PLoS ONE. 7, e41024. doi: 10.1371/journal.pone.0041024
   PubMed Web of Science ®Google Scholar
• Pearse AM, Swift K, Hodson P, et al. (2012). Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population. Cancer Genet, 205, 101–112. doi: 10.1016/j.cancergen.2011.12.001
   PubMed Web of Science ®Google Scholar
• Peppelenbosch M, Boone E, Jones GE, et al. (1999). Multiple signal transduction pathways regulate TNF-induced actin reorganization in macrophages: inhibition of Cdc42-mediated filopodium formation by TNF. J Immunol, 162, 837–845.
   PubMed Web of Science ®Google Scholar
• Pye R, Hamede R, Siddle HV, et al. (2016a). Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils. Biol Lett, 12. doi: 10.1098/rsbl.2016.0553
   Web of Science ®Google Scholar
• Pye RJ, Pemberton D, Tovar C, et al. (2016b). A second transmissible cancer in Tasmanian devils. Proc Natl Acad Sci U S A. 113, 374–379. doi: 10.1073/pnas.1519691113
   PubMed Web of Science ®Google Scholar
• Schleicher U, Bogdan C. (2009). Generation, culture and flow-cytometric characterization of primary mouse macrophages. Methods Mol. Biol., 531, 203–224. doi: 10.1007/978-1-59745-396-7_14
   PubMedGoogle Scholar
• Schleicher U, Paduch K, Debus A, et al. (2016). TNF-mediated restriction of arginase 1 expression in myeloid cells triggers type 2 NO Synthase activity at the site of infection. Cell Rep. 15, 1062–1075. doi: 10.1016/j.celrep.2016.04.001
   PubMed Web of Science ®Google Scholar
• Sedgwick JD, Riminton DS, Cyster JG, Körner H. (2000). Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol Today, 21, 110–113.
   PubMedGoogle Scholar
• Siddle HV, Kreiss A, Tovar C, et al. (2013). Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer. Proc Natl Acad Sci U S A. 110, 5103–5108. doi: 10.1073/pnas.1219920110
   PubMed Web of Science ®Google Scholar
• Tauber AI. (2003). Metchnikoff and the phagocytosis theory. Nat Rev Mol Cell Biol, 4, 897–901. doi: 10.1038/nrm1244
   PubMed Web of Science ®Google Scholar
• Taylor PR, Martinez-Pomares L, Stacey M, et al. (2005). Macrophage receptors and immune recognition. Annu Rev Immunol, 23, 901–944. doi: 10.1146/annurev.immunol.23.021704.115816
   PubMed Web of Science ®Google Scholar
• Tjelle TE, Lovdal T, Berg T. (2000). Phagosome dynamics and function. Bioessays, 22, 255–263. doi: 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R
   PubMed Web of Science ®Google Scholar
• Tovar C, Pye RJ, Kreiss A, et al. (2017). Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils. Sci Rep. 7, 43827. doi: 10.1038/srep43827
   PubMed Web of Science ®Google Scholar
• Underhill DM, Ozinsky A. (2002). Phagocytosis of microbes: complexity in action. Annu Rev Immunol, 20, 825–852. doi: 10.1146/annurev.immunol.20.103001.114744
   PubMed Web of Science ®Google Scholar
• Varin A, Mukhopadhyay S, Herbein G, Gordon S. (2010). Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood, 115, 353–362. doi: 10.1182/blood-2009-08-236711
   PubMed Web of Science ®Google Scholar
• Vila-Del Sol V, Punzon C, Fresno M. (2008). IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J Immunol, 181, 4461–4470.
   PubMed Web of Science ®Google Scholar
• Wilhelm P, Ritter U, Labbow S, et al. (2001). Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J. Immunol., 166, 4012–4019.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Yu X. (2008). Phagosome maturation during the removal of apoptotic cells: receptors lead the way. Trends Cell Biol, 18, 474–485. doi: 10.1016/j.tcb.2008.08.002
   PubMed Web of Science ®Google Scholar